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Background: The risk of neoplastic transformation in patients with chronic thyroiditis (Hashimoto’s thyroiditis – HT)
is slightly increased. Genetic background of this observation is still unclear. PI3K isoforms are linked with
inflammatory and neoplastic processes, thus they appear to be interesting subjects of a research in this respect. The
aim of our study was to assess the PIK3CA, PIK3CB, PIK3CD and PIK3CG genes expression levels in HT.
Methods: Following conventional cytological examination, 67 thyroid FNAB specimens, received from patients with
HT, were quantitatively evaluated regarding PIK3CA, PIK3CB, PIK3CD and PIK3CG expression levels by real-time PCR in
the ABI PRISM W7500 Sequence Detection System.
Results: The performed analysis has revealed significantly higher expression levels (RQ) of PIK3CD, PIK3CG and
PIK3CA genes in comparison with PIK3CB gene (p<0.05) and significantly higher gene expression level of PIK3CD in
comparison with PIK3CA (p<0.05).
Conclusion: The observed increased PIK3CD, PIK3CG genes expression in HT is probably related to lymphocyte
infiltration commonly seen in this condition, however, the role of increased PIK3CA gene expression in the
multi-step carcinogenesis process cannot be excluded.
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Inflammatory processes protect the body against infec-
tion and injury, however, if not satisfactorily regulated, it
can lead to destructive consequences, including the de-
velopment of autoimmune diseases. The inflammation
has also been proved to play an important role in other
diseases which have not previously been considered to
possess inflammatory etiology, e.g. such as cancer. Like-
wise, a number of researchers reported on an association
between chronic thyroiditis (Hashimoto’s thyroiditis – HT)
and a risk of thyroid neoplastic transformation.
The PI3K (phosphoinositide 3-kinase) signaling path-
way regulates numerous cell functions in both normal
and pathological states. Class I PI3K consists of four iso-
foms of the catalytic subunits, p110α, -β, -δ, -γ, coded by
PIK3CA, -B, -D and –G genes, respectively. Under basal* Correspondence: alewin@csk.umed.lodz.pl
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use, distribution, and reproduction in any medconditions, the expression of the PI3K isoforms seems to
depend on transcriptional control, with mRNA levels
correlating well with protein levels [1]. Moreover, it is
well documented that these isoforms show different tis-
sue distribution, i.e. PIK3CA and PIK3CB are expressed
ubiquitously, while PIK3CD, PIK3CG are expressed pre-
dominantly in leucocytes [2].
Considering thyroid neoplasms, the increased activation
of PI3K pathway could be related to mutations and/or
amplification of PIK3CA gene and amplification of PIK3CB
gene [3]. Additionally, several reports demonstrate that
PIK3CD and PIK3CG subunits are essential in regulating
chemokine production by leukocytes, as well as directional
migration of these cells during the inflammatory process
[2,3]. Thus, a role of PI3K isoforms in the thyroid immune
response linked with inflammation and cancer appears to
be an interesting subject of a research.
The aim of our study was to assess the PIK3CA,
PIK3CB, PIK3CD and PIK3CG genes expression levels
in HT.see BioMed Central Ltd. This is an Open Access article distributed under the
icense (http://creativecommons.org/licenses/by/2.0), which permits unrestricted
ium, provided the original work is properly cited.
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The study was approved by the Ethics Committee of the
Medical University of Lodz, Poland. Written consent
was obtained from all the patients subjected to the fine
needle aspiration biopsy (FNAB).
Cytological specimens from 67 patients (64 women,
3 men) with chronic thyroiditis were analyzed. Follow-
ing preparation of smears for cytological examination,
extraction of total RNA from remnant biopsy needle
material was obtained by an RNeasy Micro Kit (Qiagen),
using modified Chomczynski and Sacchi’s method.
The purity of total RNA was assessed by NanoDropW
ND-100 spectrophotometr. One hundred nanogram of
total RNA was used in the first strand cDNA synthesis
with TaqManW Reverse Transcription Reagents (Applied
Biosystems), according to manufacturers’ instruction.
Real-time PCR was performed on the ABI PRISMW
7500 Sequence Detection System (Applied Biosystems)
by using TaqManW Universal PCR Master Mix (Applied
Biosystems) and TaqManW Gene Expression Assays
probe and primer mix (Applied Biosystems) accord-
ing to the manufacturers’ specification. The Assay Iden-
tification numbers were: PIK3CA - Hs00180679_m1;
PIK3CB - Hs00178872_m1; PIK3CD - Hs00192399_m1;
PIK3CG - Hs00176916_m1. Thermal cycler conditions
were as follows: hold for 10 min. at 95°C, followed by









Figure 1 Box-and-whisker plots representing the expression of PIK3C
calculated as RQ values. Whiskers represent standard deviation for particula
means. The results were statistically analyzed, using Kruskal-Wallis’ and Newby 60°C for 1 min. Amplification reactions were per-
formed in triplicate for each sample, and the results were
normalized to the ACTB gene expression level (ACTB
Assay Identification number: Hs99999903_m1). Macro-
scopically unchanged thyroid tissue, surgically removed
from patients with nodular goitre, served as a control for
real-time PCR experiment.
An analysis of relative gene expression data was per-
formed, using the 2-ΔΔCT method on an ABI PRISMW
7500 Sequence Detection System Software (Applied Bio-
systems). The fold change in studied gene expression,
normalised to endogenous control, was calculated using
formula: RQ = 2-ΔΔCT.
In order to compare the relative expression (RQ) of
PIK3CA, PIK3CB, PIK3CD and PIK3CG genes in HT,
the data were statistically analysed using Kruskal-Wallis’
and Newman-Keuls’ tests. In all analyses, statistical sig-
nificance was considered achieved at a value of p<0.05.Results
The performed analysis has revealed significantly higher
expression levels (RQ) of PIK3CD, PIK3CG and PIK3CA
genes in comparison with PIK3CB gene (p<0.05). Fur-
ther statistical analysis proved significantly higher gene
expression level of PIK3CD in comparison with PIK3CA
(p<0.05) (Figure 1, 2).Mean
Mean±SEM
Mean±SDG PIK3CB
A, PIK3CB, PIK3CD and PIK3CG genes in HT. The results are















Figure 2 Box-and-whisker plots representing the expression of PIK3CA, PIK3CB, PIK3CD and PIK3CG genes in HT. The results are
calculated as RQ values. Whiskers represent minimum and maximum value for particular genes. Boxes represent lower quartile and upper quartile
of values. Small boxes illustrate median values. The results were statistically analyzed, using Kruskal-Wallis’ and Newman-Keuls’ tests (p<0.05).
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Chronic thyroiditis affects a significant portion of endo-
crinologic patients, with considerable quality-of-life bur-
den. When discussing chronic thyroiditis, it is worth
stressing that former studies revealed infiltration of thy-
roid tissue by a mixed population of T and B lympho-
cytes [4]. Moreover, chronic thyroiditis is characterized
by the presence of thyroid antibodies; antibodies against
thyroperoxidase (TPO) are the most specific ones.
PI3K isoforms control inflammation processes at many
levels, from the generation of inflammatory cells to their
migration and function. However, the precise role of
PI3K in the regulation of immune process in the thyroid
remains open to refinement. Genetic approaches have
been employed to assess the contribution of class I PI3K
isoforms in thyroid immune process. Our present find-
ings have confirmed increased expression of PIK3CA,
PIK3CD and PIK3CG genes and decreased expression of
PIK3CB gene in HT. Further statistical analysis has
revealed the increased expression level of PIK3CD in
comparison with PIK3CA.
Our results are partially in agreement with previous
observations that PIK3CD subunit is expressed at high
levels in lymphocytes and lymphoid tissue and may –
therefore - play a role in PI3K mediated signaling in the
immune system [5]. In addition, PIK3CD has been
implicated in leukocyte endothelial transmigration du-
ring inflammation [6] but it is not clear whether thiseffect is caused by PIK3CD expression in leukocytes
themselves, in endothelial cells or by both.
The role of PIK3CD isoform in thyroid carcinogenesis
remains to be determined, however it is worth stressing
that PIK3CD contributes in other neoplastic processes.
In acute myeloid leukemia cells, PIK3CD is the only
class I PI3K isoform that consistently is detected [7,8].
At the same time, PIK3CD is expressed to moderate de-
gree in certain neoplastic cells of non-leukocyte origin,
such as melanoma cells, breast and colon cancer cells.
However, large discrepancies in expression levels in cell
lines, even of the same tissue origin, were noted [9].
The explanation of our findings can also be related
to the process of antibodies generation which requires col-
laboration between B and T cells within germinal centers,
the process in which PIK3CD subunit is essential in T cells
just for the germinal centre reaction. Additionally, it has
also been found that formation of T follicular helper cells
is critically dependent on PIK3CD [10].
Furthermore, the contribution of PIK3CD subunit in
other autoimmune disorders, like rheumatoid arthritis
has also been confirmed and PIK3CD is a promising
therapeutic target in this disease because of its role to
leukocyte biology [11]. It has also been demonstrated
that PIK3CD is a major regulator of PDGF-mediated
fibroblast growth [11], the observation which can sup-
port the role of PIK3CD also in the process of thyroid fi-
brosis in HT.
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high expression of PIK3CG gene in HT. It has previously
been regarded that PIK3CG subunit is required to allow
chemotactic migration of neutrophils, macrophages, and
effector CD8 T cells to inflammatory sites [12,13]. The
increased PIK3CG gene copy number has been docu-
mented in ovarian cancer, as well [14].
Previous findings by Ghigo et al. [15], together with
our present observations, suggest that PIK3CD and
PIKCG can be involved in inflammation processes and can
influence the immune system. Both PIK3CD and PIK3CG
had also been identified as validated drug targets in im-
mune and inflammatory diseases [16]. Nevertheless, the
non-redundant but related roles of PIK3CD and PIK3CG
have made it difficult to determine which of the two iso-
forms (alone or in combination) is best targeted in a par-
ticular inflammatory disorder.
However, it should be recalled that the increased ex-
pression of p110 isoform, especially of isoform of p110α,
induced also oncogenic transformation [3]. Amplifica-
tion and mutations in PIK3CA gene have been reported
in many human cancers, including thyroid cancer, espe-
cially in follicular thyroid carcinoma and undifferen-
tiated thyroid carcinoma [3]. Still, little is known about
the precise role of PIK3CA gene in inflammatory disor-
ders in thyroid gland, however, the increased expression
in Riedel’s thyroiditis has previously been observed in
our laboratory [17].
In conclusion, the present study speaks for contribu-
tion of PIK3CD, PIK3CG and PIK3CA isoforms to the
autoimmune processes in the thyroid. The observed
increased PIK3CD, PIK3CG genes expression in HT
is probably related to infiltration of lymphocytes, how-
ever, the role of the increased PIK3CA gene expression
in the multi-step carcinogenesis process cannot be
excluded, either.
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